28202862 Visualization

A 40 Age - year Age - old Age woman Sex visited Clinical_event the Department Nonbiological_location of Nonbiological_location Obstetrics Nonbiological_location and Nonbiological_location Gynecology Nonbiological_location in our Nonbiological_location hospital Nonbiological_location because of a complaint of sudden Detailed_description dyspnea Sign_symptom on Detailed_description effort Detailed_description .
She was previously diagnosed with endometriosis Disease_disorder and prescribed a combination Detailed_description oral Administration contraceptive Medication pill Administration ( drospirenone Medication / ethinylestradiol Medication betadex Medication , trade Detailed_description name; Detailed_description Yaz™ Detailed_description , Bayer, Detailed_description Leverkusen, Detailed_description Germany Detailed_description ).
Following the Kumamoto Other_event Earthquakes Other_event and subsequent aftershocks Other_event in April Date 2016 Date , she spent Activity 7 Duration nights Duration in a vehicle Nonbiological_location .
She noticed sudden Detailed_description dyspnea Sign_symptom on Detailed_description effort Detailed_description when she walked Clinical_event outside Nonbiological_location the car on the 8th Date morning Date after Date the first Other_event earthquake Other_event .
Although she walked Activity around Activity for personal reasons during the daytime, she spent Activity nights Activity in her small Nonbiological_location car Nonbiological_location with her legs Biological_structure in a hanging Detailed_description position Detailed_description .
She noticed swelling Sign_symptom and pain Sign_symptom in her left Biological_structure lower Biological_structure extremity Biological_structure , and her serum Diagnostic_procedure D Diagnostic_procedure - dimer Diagnostic_procedure levels were 13.2 Lab_value μg/mL.
Deep Disease_disorder vein Disease_disorder thrombosis Disease_disorder ( DVT Disease_disorder ) was suspected by her home Nonbiological_location doctor Nonbiological_location .
A contrast Detailed_description - enhanced Detailed_description computed Diagnostic_procedure tomography Diagnostic_procedure (CT)-scan revealed a contrast Sign_symptom deficit Sign_symptom in the bilateral Biological_structure pulmonary Biological_structure artery Biological_structure (Fig.2A) and in the left Biological_structure lower Biological_structure extremity Biological_structure ( posterior Detailed_description tibial, Detailed_description soleus Detailed_description and Detailed_description gastrocnemius Detailed_description vein Detailed_description ) (Fig.2B).
Her right Diagnostic_procedure ventricular Diagnostic_procedure function Diagnostic_procedure was intact Lab_value (estimated pulmonary Diagnostic_procedure artery Diagnostic_procedure pressure=29/8 mmHg Lab_value in cardiac Biological_structure ultrasound Diagnostic_procedure ).
Her plasma Detailed_description brain Diagnostic_procedure natriuretic Diagnostic_procedure peptide Diagnostic_procedure and high Detailed_description - sense Detailed_description troponin Diagnostic_procedure T Diagnostic_procedure concentration Diagnostic_procedure levels were 97.2 Lab_value pg/mL Lab_value and 0.0061 Lab_value ng/mL Lab_value , respectively.
She was diagnosed with PTE Disease_disorder and admitted Clinical_event to our department Nonbiological_location .
On admission Clinical_event , her blood Diagnostic_procedure pressure Diagnostic_procedure was 129/80 Lab_value mmHg Lab_value and her heart Diagnostic_procedure rate Diagnostic_procedure was 72 Lab_value beats Lab_value per Lab_value minute Lab_value .
Her degree of oxygen Diagnostic_procedure saturation Diagnostic_procedure ( SaO2 Diagnostic_procedure ) in arterial Detailed_description blood Detailed_description gas Detailed_description was 97.7% Lab_value .
Her body Diagnostic_procedure mass Diagnostic_procedure index Diagnostic_procedure was 24.4 Lab_value kg/m2 Lab_value .
Electrocardiography Diagnostic_procedure and cardiac Biological_structure ultrasound Diagnostic_procedure did not indicate heart Disease_disorder failure Disease_disorder .
An investigation of most factors Diagnostic_procedure related Diagnostic_procedure to Diagnostic_procedure thrombus Diagnostic_procedure formation Diagnostic_procedure (including protein Diagnostic_procedure C Diagnostic_procedure , protein Diagnostic_procedure S Diagnostic_procedure , antithrombin Diagnostic_procedure , and antiphospholipid Diagnostic_procedure antibodies Diagnostic_procedure ) revealed that all such factors were normal Lab_value .
The discontinuation of the oral Administration contraceptive Medication and the administration of rivaroxaban Medication ( 30 Dosage mg, Dosage daily Dosage ), a direct Detailed_description oral Administration anticoagulant Medication ( trade Detailed_description name: Detailed_description Xarelto™ Detailed_description , Bayer Detailed_description ) was initiated according Detailed_description to Detailed_description the Detailed_description results Detailed_description of Detailed_description the Detailed_description EINSTEIN Detailed_description - PE Detailed_description trial Detailed_description (3).
After Date 7 Date days Date , a follow Clinical_event - up Clinical_event contrast Detailed_description - enhanced Detailed_description CT Diagnostic_procedure scan revealed a reduction in the thrombosis Disease_disorder (Fig.3).
The patient was followed Clinical_event up Clinical_event with rivaroxaban Medication .
The patient gave her consent for the publication of this study.